{
  "meta": {
    "id": "test7",
    "title": "Pharmacology E&D - Mission 2.0 (Batch 2) - 27-09-2024 - 2024-09-27",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 52-year-old female patient is undergoing chemotherapy for breast cancer. The oncology team is concerned about the risk of febrile neutropenia due to the chemotherapeutic regimen. They are contemplating the use of a granulocyte colony-stimulating factor (G-CSF) and discuss the option of using pegylated-filgrastim or filgrastim. Which of the following is true about pegylated-filgrastim as compared to filgrastim?",
      "options": [
        {
          "label": "A",
          "text": "Duration of action is longer than filgrastim",
          "correct": true
        },
        {
          "label": "B",
          "text": "Added advantage is that it can be taken orally",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pegylated filgrastim is GM-CSF whereas filgrastim is G-CSF.",
          "correct": false
        },
        {
          "label": "D",
          "text": "It is not effective in the treatment of severe neutropenia.",
          "correct": false
        }
      ],
      "correct_answer": "A. Duration of action is longer than filgrastim",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Duration of action is longer than filgrastim.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1d241898",
      "audio": ""
    },
    {
      "text": "A 35-year-old male patient is being treated for chronic neuropathic pain with an oral medication. The healthcare team monitors the drug's plasma concentration over time. Which parameter on the plasma concentration vs. time graph helps to guide dose adjustments to maximize efficacy without causing toxicity?",
      "options": [
        {
          "label": "A",
          "text": "AUC",
          "correct": false
        },
        {
          "label": "B",
          "text": "T1/2",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cmax",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tmax",
          "correct": false
        }
      ],
      "correct_answer": "C. Cmax",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Cmax</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Important points about the PC-T graph:</li><li>\u27a4 Cmax helps assess peak drug levels for efficacy and toxicity. Tmax indicates the rate of absorption. AUC tells about extent of drug absorption. T1/2 helps determine dosing intervals.</li><li>\u27a4 Cmax helps assess peak drug levels for efficacy and toxicity.</li><li>\u27a4 Cmax</li><li>\u27a4 Tmax indicates the rate of absorption.</li><li>\u27a4 Tmax</li><li>\u27a4 AUC tells about extent of drug absorption.</li><li>\u27a4 AUC</li><li>\u27a4 T1/2 helps determine dosing intervals.</li><li>\u27a4 T1/2</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "301f8153",
      "audio": ""
    },
    {
      "text": "Acetylcholine acts through M3 receptor stimulation to cause increase in GI motility whereas adrenaline acts via beta 2 receptors to cause decrease in GI motility. Which type of antagonism it is?",
      "options": [
        {
          "label": "A",
          "text": "Pharmacological antagonism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chemical antagonism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Physical antagonism",
          "correct": false
        },
        {
          "label": "D",
          "text": "Physiological antagonism",
          "correct": true
        }
      ],
      "correct_answer": "D. Physiological antagonism",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Physiological Antagonism</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Physiological antagonism occurs when two drugs act on different receptors or pathways to produce opposite physiological effects, without interacting directly. This is in contrast to pharmacological antagonism , where two drugs compete for the same receptor, and chemical antagonism , where two substances chemically neutralize each other. Understanding the type of antagonism is critical in predicting and managing drug interactions in clinical practice.</li><li>\u27a4 Physiological antagonism</li><li>\u27a4 pharmacological antagonism</li><li>\u27a4 chemical antagonism</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c4e8ecba",
      "audio": ""
    },
    {
      "text": "Identify the type of inhibition given in the graph?",
      "options": [
        {
          "label": "A",
          "text": "Competitive",
          "correct": false
        },
        {
          "label": "B",
          "text": "Un-competitive",
          "correct": false
        },
        {
          "label": "C",
          "text": "Non-competitive",
          "correct": false
        },
        {
          "label": "D",
          "text": "Mixed",
          "correct": true
        }
      ],
      "correct_answer": "D. Mixed",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-155752.png"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-155830.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-155836.png"
      ],
      "explanation": "<p><strong>Ans. D) Mixed</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c3079022",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a correct match of the adverse effect and mechanism of action of imipramine?",
      "options": [
        {
          "label": "A",
          "text": "Sedation - H1 receptor blockade",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dry mouth \u2013 M3 Muscarinic receptor blockade",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sexual dysfunction\u2013 5HT reuptake inhibition",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypotension \u2013 D2 receptor blockade",
          "correct": true
        }
      ],
      "correct_answer": "D. Hypotension \u2013 D2 receptor blockade",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-160013.png"
      ],
      "explanation": "<p><strong>Ans. D) Hypotension \u2013 D2 receptor blockade</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5a189249",
      "audio": ""
    },
    {
      "text": "In a dog blood pressure experiment, a researcher injected phentolamine first followed by epinephrine and the recordings of the effect are shown in the diagram given below. This phenomenon is known as?",
      "options": [
        {
          "label": "A",
          "text": "Tachyphylaxis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Biphasic response of epinephrine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vasomotor reversal of Dale",
          "correct": true
        },
        {
          "label": "D",
          "text": "Phentolamine epinephrine coupling",
          "correct": false
        }
      ],
      "correct_answer": "C. Vasomotor reversal of Dale",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/6.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Vasomotor reversal of Dale</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "10fd511f",
      "audio": ""
    },
    {
      "text": "A 55-year-old man who received a kidney transplant three months ago is admitted to the hospital with high-grade fever, malaise, and abdominal discomfort. On examination, he exhibits right upper quadrant tenderness. Lab investigations reveal abnormal liver enzymes, and a blood culture returns positive for cytomegalovirus (CMV). His current immunosuppressive regimen includes tacrolimus. What is the primary pharmacological action of tacrolimus that might have predisposed this patient to develop a CMV infection?",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of calcineurin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Blockade of IL-2 receptor",
          "correct": false
        },
        {
          "label": "C",
          "text": "IMP dehydrogenase inhibition",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dihydro-orotate dehydrogenase inhibition",
          "correct": false
        }
      ],
      "correct_answer": "A. Inhibition of calcineurin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Inhibition of calcineurin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of all the options:</li><li>\u2022 A) Inhibition of calcineurin: Tacrolimus acts by inhibiting calcineurin, which plays a pivotal role in T-cell activation. This immunosuppressive action can make the patient susceptible to infections such as CMV.</li><li>\u2022 B) Blockade of IL-2 receptor: This is a mechanism of other immunosuppressive drugs like basiliximab but not tacrolimus. Therefore, it is not relevant to the patient's current condition.</li><li>\u2022 C) IMP dehydrogenase inhibition: This is the mechanism of mycophenolate mofetil, another immunosuppressive drug. It is not applicable to tacrolimus.</li><li>\u2022 D) Dihydro-orotate dehydrogenase inhibition: This mechanism is associated with drugs like leflunomide but is not relevant to the action of tacrolimus.</li><li>\u2022 Thus, the primary pharmacological action of tacrolimus that might have predisposed this patient to develop a CMV infection is the inhibition of calcineurin.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d73d2f39",
      "audio": ""
    },
    {
      "text": "A 60-year-old female with a history of glaucoma presents to the ophthalmologist with complaints of blurred vision and eye irritation. The patient reports that she has been using an anti-glaucoma medication for the past six months, and her symptoms began to appear gradually over the past few weeks. Appearance of eye is as shown in the figure. Which of the following anti-glaucoma drugs is likely to produce this adverse effect?",
      "options": [
        {
          "label": "A",
          "text": "Timolol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Latanoprost",
          "correct": true
        },
        {
          "label": "C",
          "text": "Brimonidine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dorzolamide",
          "correct": false
        }
      ],
      "correct_answer": "B. Latanoprost",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-160127.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Latanoprost.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2d6647af",
      "audio": ""
    },
    {
      "text": "A 70-year-old male patient with a history of heart failure and atrial fibrillation has been taking digoxin for several months. He recently started on a new medication. He presents to the clinic with symptoms of nausea, vomiting, and visual disturbances. On testing, plasma levels of digoxin were elevated. Which of the following drugs is most likely responsible for these symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Metformin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lisinopril",
          "correct": false
        },
        {
          "label": "C",
          "text": "Amlodipine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Quinidine",
          "correct": true
        }
      ],
      "correct_answer": "D. Quinidine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Quinidine</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Drugs like quinidine that inhibit P-glycoprotein can significantly increase the plasma levels of digoxin , leading to toxicity. Classic symptoms of digoxin toxicity include nausea, vomiting, confusion, and visual disturbances (e.g., yellow or blurred vision). Clinicians must be aware of potential drug interactions, particularly with medications affecting renal or hepatic excretion pathways like P-glycoprotein inhibitors. Regular monitoring of digoxin levels is essential when such drugs are co-administered.</li><li>\u27a4 quinidine</li><li>\u27a4 P-glycoprotein</li><li>\u27a4 digoxin</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3ab292e7",
      "audio": ""
    },
    {
      "text": "A 65-year-old male presents with symptoms of urinary urgency, frequency, and nocturia. He has been diagnosed with overactive bladder. On further questioning, the patients tells that he forgets the things easily and is on rivastigmine therapy for the same. Which of the following drugs is a beta-3 adrenergic receptor agonist that is effective in treating this patient's symptoms without interfering with treatment of his dementia?",
      "options": [
        {
          "label": "A",
          "text": "Tolterodine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Memantine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vibegron",
          "correct": true
        },
        {
          "label": "D",
          "text": "Levetiracetam",
          "correct": false
        }
      ],
      "correct_answer": "C. Vibegron",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For patients with overactive bladder who are also being treated for dementia , it is important to avoid antimuscarinic agents like tolterodine due to their cognitive side effects. Beta-3 adrenergic receptor agonists like vibegron are effective alternatives that increase bladder capacity without interfering with cholinergic medications like rivastigmine, thus preserving cognitive function.</li><li>\u27a4 overactive bladder</li><li>\u27a4 dementia</li><li>\u27a4 tolterodine</li><li>\u27a4 Beta-3 adrenergic receptor agonists</li><li>\u27a4 vibegron</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "84306434",
      "audio": ""
    },
    {
      "text": "The following table gives the data of AUC of drug A alone and AUC of drug A when combined with drug B. p value is <0.01. Which of the following statement regarding these drugs is most correct?",
      "options": [
        {
          "label": "A",
          "text": "Drug B decreases the first pass metabolism of drug A",
          "correct": false
        },
        {
          "label": "B",
          "text": "Drug B decreases the systemic metabolism of drug A",
          "correct": false
        },
        {
          "label": "C",
          "text": "Drug B decreases the intestinal absorption of drug A",
          "correct": true
        },
        {
          "label": "D",
          "text": "Drug B decreases the renal clearance of drug A",
          "correct": false
        }
      ],
      "correct_answer": "C. Drug B decreases the intestinal absorption of drug A",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-160441_L3vs8N9.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Drug B decreases the intestinal absorption of drug A</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The AUC represents the total drug exposure over time and is influenced by absorption, distribution, metabolism, and elimination. A significant reduction in AUC, as observed when drug A is combined with drug B, suggests that drug B is likely interfering with the absorption of drug A. When evaluating drug interactions, it\u2019s important to consider the mechanism of action (e.g., effects on absorption, metabolism, or excretion) to optimize therapeutic regimens and avoid suboptimal drug levels or adverse effects.</li><li>\u27a4 AUC</li><li>\u27a4 absorption</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d9d3c94e",
      "audio": ""
    },
    {
      "text": "A 43-year-old, insulin-dependent diabetic patient is diagnosed with migraine and begins therapy with a drug to prevent further attacks of migraine. Three days later, he measures his blood glucose at home and finds that it is 53 mg/dL. He recalibrates his glucose testing apparatus and repeats the test, only to find that the first reading was accurate. He is concerned that his hypoglycemia did not produce the normal premonitory signs and symptoms. Which of the following medications was most likely prescribed to him?",
      "options": [
        {
          "label": "A",
          "text": "Sumatriptan",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lasmiditan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ubrogepant",
          "correct": false
        },
        {
          "label": "D",
          "text": "Propranolol",
          "correct": true
        }
      ],
      "correct_answer": "D. Propranolol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Propranolol</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Propranolol , a non-selective beta-blocker, is often used for migraine prophylaxis but can mask the signs of hypoglycemia in diabetic patients by blunting the sympathetic nervous system's response. This makes it challenging for patients to detect low blood sugar, as the typical warning signs are reduced. In managing diabetic patients who require beta-blocker therapy, close monitoring of blood glucose levels is essential to avoid hypoglycemia unawareness.</li><li>\u27a4 Propranolol</li><li>\u27a4 hypoglycemia</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "78600d84",
      "audio": ""
    },
    {
      "text": "A drug effect that is produced by therapeutic doses of both timolol and amiodarone is blockade of:",
      "options": [
        {
          "label": "A",
          "text": "Cardiac Na channels",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cardiac K channels",
          "correct": false
        },
        {
          "label": "C",
          "text": "Beta-adrenoceptors",
          "correct": true
        },
        {
          "label": "D",
          "text": "Alpha-adrenoceptors",
          "correct": false
        }
      ],
      "correct_answer": "C. Beta-adrenoceptors",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Beta-adrenoceptors.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "661ae322",
      "audio": ""
    },
    {
      "text": "Metformin is least likely to reduce blood sugar in which of the following patients?",
      "options": [
        {
          "label": "A",
          "text": "Obese diabetics",
          "correct": false
        },
        {
          "label": "B",
          "text": "Non-diabetics",
          "correct": true
        },
        {
          "label": "C",
          "text": "Type 2 diabetics",
          "correct": false
        },
        {
          "label": "D",
          "text": "Diabetics not respond to sulfonylureas.",
          "correct": false
        }
      ],
      "correct_answer": "B. Non-diabetics",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Non-diabetics</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "24444d9b",
      "audio": ""
    },
    {
      "text": "A 67-year-old postmenopausal woman with a history of osteoporosis is being evaluated for potential pharmacological treatments to strengthen her bones. She has tried lifestyle modifications, including weight-bearing exercises and calcium supplements, with limited improvement. Her physician is considering various pharmacological agents to inhibit osteoclastic activity and thereby prevent further bone loss. Which of the following medications does NOT primarily act by inhibiting osteoclasts?",
      "options": [
        {
          "label": "A",
          "text": "Denosumab",
          "correct": false
        },
        {
          "label": "B",
          "text": "Strontium ranelate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Teriparatide",
          "correct": true
        },
        {
          "label": "D",
          "text": "Raloxifene",
          "correct": false
        }
      ],
      "correct_answer": "C. Teriparatide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Teriparatide</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Options:</li><li>\u2022 a) Denosumab: This is a monoclonal antibody that inhibits the RANKL (Receptor Activator for Nuclear Factor \u03ba B Ligand), which is essential for the formation and function of osteoclasts. Thus, it inhibits osteoclast activity.</li><li>\u2022 b) Strontium ranelate: This drug is used in the treatment of osteoporosis and works by both promoting bone formation and inhibiting bone resorption. It is thought to inhibit osteoclasts, although the exact mechanism is not well understood.</li><li>\u2022 c) Teriparatide: This is the correct answer. Teriparatide is a recombinant form of parathyroid hormone. It is actually an anabolic (bone-building) agent that stimulates osteoblast activity, rather than inhibiting osteoclasts.</li><li>\u2022 d) Raloxifene: This is a selective estrogen receptor modulator (SERM) that inhibits bone resorption by osteoclasts, thus serving to preserve bone mass in conditions like osteoporosis.</li><li>\u2022 Teriparatide does not inhibit osteoclasts but stimulates osteoblasts, making it the correct answer for the drug that does not act by inhibiting osteoclasts.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "91f36b20",
      "audio": ""
    },
    {
      "text": "A 48-year-old woman goes to her dermatologist to have a mole removed. The patient tells her physician that she had an allergic reaction to a local anesthetic the last time she had dental work performed. Examination of her dental records by her dentist reveals that the patient received tetracaine for a tooth extraction. Which of the following drugs would be appropriate for the present procedure?",
      "options": [
        {
          "label": "A",
          "text": "Chlorprocaine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Prilocaine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cocaine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Benzocaine",
          "correct": false
        }
      ],
      "correct_answer": "B. Prilocaine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Prilocaine</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "70df17ed",
      "audio": ""
    },
    {
      "text": "Following the treatment of an oral abscess with clindamycin, a patient develops a greenish, foul-smelling watery diarrhea with left lower quadrant pain. Other signs and symptoms include fever, leukocytosis, and lethargy. If the toxin produced by Clostridium difficile is detected in the stool, the patient would most appropriately be treated with:",
      "options": [
        {
          "label": "A",
          "text": "Fidaxomicin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Intravenous vancomycin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Loperamide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metronidazole",
          "correct": false
        }
      ],
      "correct_answer": "A. Fidaxomicin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Fidaxomicin.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e0c175da",
      "audio": ""
    },
    {
      "text": "A 45-year-old female presents to the clinic with a palpable lump in her left breast that she noticed while showering. She reports no associated pain, discharge, or skin changes. Her past medical history is unremarkable, and she has no known family history of breast or ovarian cancer. Her last mammogram was two years ago and showed no abnormalities. After appropriate investigations including mammogram, ultrasound, and biopsy, she is diagnosed with stage II breast cancer. The biopsy reveals that the cancer is HER2-positive, but estrogen receptor (ER) and progesterone receptor (PR) negative. Which of the following oral drugs is likely to be effective in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Trastuzumab",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tamoxifen",
          "correct": false
        },
        {
          "label": "C",
          "text": "Letrozole",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lapatinib",
          "correct": true
        }
      ],
      "correct_answer": "D. Lapatinib",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Lapatinib</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In HER2-positive breast cancer, treatments that specifically target the HER2 receptor, such as lapatinib (an oral tyrosine kinase inhibitor), are effective. These cancers do not respond to hormonal therapies like tamoxifen or letrozole , which target estrogen receptor-positive breast cancers. Understanding the molecular profile of the cancer is essential in choosing the most effective treatment, as therapies are tailored to the specific receptors expressed by the tumor cells.</li><li>\u27a4 lapatinib</li><li>\u27a4 tamoxifen</li><li>\u27a4 letrozole</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d158b5ae",
      "audio": ""
    },
    {
      "text": "A 50-year-old man presents to the clinic with recurrent episodes of renal colic. Laboratory tests and imaging confirm the presence of high-calcium renal stones. He has no other significant past medical history. What is the most useful diuretic in the treatment of his recurrent calcium stones?",
      "options": [
        {
          "label": "A",
          "text": "Furosemide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Spironolactone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hydrochlorthiazide",
          "correct": true
        },
        {
          "label": "D",
          "text": "Acetazolamide",
          "correct": false
        }
      ],
      "correct_answer": "C. Hydrochlorthiazide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Hydrochlorothiazide.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "adddf720",
      "audio": ""
    },
    {
      "text": "A 35-year-old man is scheduled for emergency surgery due to acute appendicitis. He has no significant past medical history, but his medical team is concerned about the use of succinylcholine as a neuromuscular blocking agent for intubation. Which of the following statements about succinylcholine is true?",
      "options": [
        {
          "label": "A",
          "text": "It may induce life-threatening hyperkalemia.",
          "correct": true
        },
        {
          "label": "B",
          "text": "It has a long duration of action.",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is the drug of choice in non-traumatic rhabdomyolysis.",
          "correct": false
        },
        {
          "label": "D",
          "text": "It is useful in patients with spinal cord injuries with paraplegia.",
          "correct": false
        }
      ],
      "correct_answer": "A. It may induce life-threatening hyperkalemia.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. It may induce life-threatening hyperkalemia.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d58f687e",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman presents with acute liver and renal failure. Her lab reports show a serum bilirubin level of 8 mg/dl and a serum creatinine level of 4 mg/dl. She requires muscle relaxation for mechanical ventilation. What would be the muscle relaxant of choice in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Pancuronium",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mivacurium",
          "correct": false
        },
        {
          "label": "C",
          "text": "Atracurium",
          "correct": true
        },
        {
          "label": "D",
          "text": "d-Tubocurarine",
          "correct": false
        }
      ],
      "correct_answer": "C. Atracurium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Atracurium.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "58507242",
      "audio": ""
    },
    {
      "text": "Which of the following combination of drug and its indication is FALSE?",
      "options": [
        {
          "label": "A",
          "text": "Pretomanid: MDR tuberculosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Enfuvirtide: Treatment of HIV",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tafenoquine: Single dose treatment of P. falciparum malaria",
          "correct": true
        },
        {
          "label": "D",
          "text": "Remdesivir: Moderate to severe COVID-19 pneumonia",
          "correct": false
        }
      ],
      "correct_answer": "C. Tafenoquine: Single dose treatment of P. falciparum malaria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Tafenoquine: Single dose treatment of P. falciparum malaria</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tafenoquine is used for the radical cure of P. vivax malaria and is not indicated for single-dose treatment of P. falciparum malaria . First-line treatment for P. falciparum malaria typically involves artemisinin-based combination therapies (ACTs) . Pretomanid is crucial in the treatment of MDR tuberculosis, and Enfuvirtide is used in HIV management. Remdesivir is an antiviral used in moderate to severe cases of COVID-19 pneumonia.</li><li>\u27a4 Tafenoquine is used for the radical cure of P. vivax malaria and is not indicated for single-dose treatment of P. falciparum malaria .</li><li>\u27a4 Tafenoquine</li><li>\u27a4 P. vivax malaria</li><li>\u27a4 P. falciparum malaria</li><li>\u27a4 First-line treatment for P. falciparum malaria typically involves artemisinin-based combination therapies (ACTs) .</li><li>\u27a4 P. falciparum malaria</li><li>\u27a4 artemisinin-based combination therapies (ACTs)</li><li>\u27a4 Pretomanid is crucial in the treatment of MDR tuberculosis, and Enfuvirtide is used in HIV management.</li><li>\u27a4 Pretomanid</li><li>\u27a4 Enfuvirtide</li><li>\u27a4 Remdesivir is an antiviral used in moderate to severe cases of COVID-19 pneumonia.</li><li>\u27a4 Remdesivir</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a015a76f",
      "audio": ""
    },
    {
      "text": "A 27-year-old male diagnosed with HIV seeks guidance from his primary care doctor for appropriate treatment. Given the significant drop in his CD4 counts, initiation of HAART (Highly Active Antiretroviral Therapy) is being contemplated. Concerning the role of ritonavir for this patient, which statement holds true?",
      "options": [
        {
          "label": "A",
          "text": "Ritonavir is commonly used to inhibit the HIV protease enzyme along with other drugs in HAART regimen.",
          "correct": false
        },
        {
          "label": "B",
          "text": "This agent is associated with resistance when used in combination with another protease inhibitor.",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is used primarily for its inhibitory effect on CYP3A4.",
          "correct": true
        },
        {
          "label": "D",
          "text": "This is an excellent single agent for use in HAART therapy.",
          "correct": false
        }
      ],
      "correct_answer": "C. It is used primarily for its inhibitory effect on CYP3A4.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. It is used primarily for its inhibitory effect on CYP3A4.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Other Options</li><li>\u2022 A. Ritonavir is commonly used to inhibit the HIV protease enzyme along with other drugs in HAART regimen.</li><li>\u2022 A. Ritonavir is commonly used to inhibit the HIV protease enzyme along with other drugs in HAART regimen.</li><li>\u2022 While ritonavir does have protease inhibitory activity, its primary role in HAART regimens is as a pharmacokinetic enhancer of other protease inhibitors rather than as the main protease inhibitor.</li><li>\u2022 B. This agent is associated with resistance when used in combination with another protease inhibitor.</li><li>\u2022 B. This agent is associated with resistance when used in combination with another protease inhibitor.</li><li>\u2022 Ritonavir, when used in low doses as a booster, does not contribute significantly to resistance. Its role is to increase the effectiveness of other protease inhibitors without leading to increased resistance.</li><li>\u2022 D. This is an excellent single agent for use in HAART therapy.</li><li>\u2022 D. This is an excellent single agent for use in HAART therapy.</li><li>\u2022 Ritonavir is not used as a single agent in HAART therapy due to its side effect profile and the development of resistance when used alone. It is always used in combination with other antiretroviral drugs.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ritonavir is primarily used in HAART regimens for its strong inhibitory effect on the cytochrome P450 enzyme CYP3A4. This inhibition enhances the pharmacokinetics of other protease inhibitors, increasing their plasma levels and efficacy, which allows for lower dosages and reduced side effects.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7812ec98",
      "audio": ""
    },
    {
      "text": "A 24-year-old Indian man, pursuing his post-graduation, recently returned from Africa where he completed an academic research project. A few weeks after his return, he visits the hospital after testing positive for Plasmodium vivax malaria. The doctor recommends primaquine for the radical cure of his P. vivax infection. Shortly after beginning the regimen, the patient exhibits yellowing of the eyes. What could be the most probable reason for this symptom?",
      "options": [
        {
          "label": "A",
          "text": "Primaquine merely stains the tears yellow; this isn't genuine yellowing of the eyes.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Interaction with another medication.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Deficiency of a specific enzyme.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Primaquine's liver-damaging effects.",
          "correct": false
        }
      ],
      "correct_answer": "C. Deficiency of a specific enzyme.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Deficiency of a specific enzyme.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4ef43e08",
      "audio": ""
    },
    {
      "text": "A 29-year-old sexually active, HIV-negative male visits his healthcare provider with a painless sore on his inner lip and a non-itchy rash on the soles of his feet. He recalls having a non-tender ulcer on his scrotum about a month and a half ago, which resolved on its own. He receives an intramuscular injection of benzathine penicillin G and is discharged. How might the treatment approach for this patient have been modified?",
      "options": [
        {
          "label": "A",
          "text": "The choice of antibiotic was not appropriate, and another class should have been selected.",
          "correct": false
        },
        {
          "label": "B",
          "text": "The correct treatment would involve a different form of penicillin G, rather than benzathine.",
          "correct": false
        },
        {
          "label": "C",
          "text": "There is no need for changes; the treatment administered is correct.",
          "correct": true
        },
        {
          "label": "D",
          "text": "After the initial injection, a follow-up dose should be given after 7 days.",
          "correct": false
        }
      ],
      "correct_answer": "C. There is no need for changes; the treatment administered is correct.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/04/screenshot-2023-09-04-125631.jpg"
      ],
      "explanation": "<p><strong>Ans. C. There is no need for changes; the treatment administered is correct.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "96cb5536",
      "audio": ""
    },
    {
      "text": "A 34-year-old woman presents to the clinic with symptoms of fever, weight loss, and splenomegaly. She has recently returned from a trip to a region known for endemic visceral leishmaniasis, also known as Kala-azar. Which of the following medications is suitable for single-dose treatment of Kala-azar?",
      "options": [
        {
          "label": "A",
          "text": "Pentamidine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Liposomal Amphotericin B",
          "correct": true
        },
        {
          "label": "C",
          "text": "Sodium stibogluconate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Miltefosine",
          "correct": false
        }
      ],
      "correct_answer": "B. Liposomal Amphotericin B",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Liposomal Amphotericin B</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f47c2ac8",
      "audio": ""
    },
    {
      "text": "35-year-old patient presents to the clinic with a swollen, painful abscess on the forehead that is discharging pus. The clinical findings strongly suggest a pus-forming gram-positive bacterial infection. Which of the following antibiotics is LEAST likely to be effective for treating this infection?",
      "options": [
        {
          "label": "A",
          "text": "Amoxycillin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cloxacillin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cotrimoxazole",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cephalexin",
          "correct": false
        }
      ],
      "correct_answer": "C. Cotrimoxazole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Cotrimoxazole</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Amoxycillin: An aminopenicillin effective against many gram-positive bacteria, often utilized for skin infections. Cloxacillin: An isoxazolyl penicillin designed to counter gram-positive bacteria, especially strains of Staphylococcus aureus. Cotrimoxazole (Trimethoprim-sulfamethoxazole): Although it has broad-spectrum activity, Cotrimoxazole is not the preferred choice for purulent (pus-forming) gram-positive skin infections. Its efficacy can be reduced in the presence of pus, and it's not the primary choice for such infections. Cephalexin: A first-generation cephalosporin that effectively targets gram-positive cocci and is often employed for skin and soft tissue infections.</li><li>\u2022 Amoxycillin: An aminopenicillin effective against many gram-positive bacteria, often utilized for skin infections.</li><li>\u2022 Cloxacillin: An isoxazolyl penicillin designed to counter gram-positive bacteria, especially strains of Staphylococcus aureus.</li><li>\u2022 Cotrimoxazole (Trimethoprim-sulfamethoxazole): Although it has broad-spectrum activity, Cotrimoxazole is not the preferred choice for purulent (pus-forming) gram-positive skin infections. Its efficacy can be reduced in the presence of pus, and it's not the primary choice for such infections.</li><li>\u2022 Cephalexin: A first-generation cephalosporin that effectively targets gram-positive cocci and is often employed for skin and soft tissue infections.</li><li>\u2022 In the context of a purulent skin infection, Cotrimoxazole is less likely to be effective compared to the other options presented.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "913d902e",
      "audio": ""
    },
    {
      "text": "A 65-year-old male with a history of diabetes presents to the hospital with a fever and worsening redness, swelling, and tenderness around his right leg. His blood cultures show methicillin-resistant Staphylococcus aureus (MRSA). The patient is started on intravenous vancomycin for suspected MRSA cellulitis. Which of the following is a true statement regarding vancomycin?",
      "options": [
        {
          "label": "A",
          "text": "It is bacteriostatic",
          "correct": false
        },
        {
          "label": "B",
          "text": "It has the advantage of high oral bioavailability",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is highly effective against Pseudomonas",
          "correct": false
        },
        {
          "label": "D",
          "text": "It is not susceptible to penicillinases",
          "correct": true
        }
      ],
      "correct_answer": "D. It is not susceptible to penicillinases",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) It is not susceptible to penicillinases</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vancomycin is a bactericidal glycopeptide antibiotic that is primarily effective against Gram-positive organisms, including MRSA. It has poor oral bioavailability and is not effective against Gram-negative bacteria like Pseudomonas . Importantly, vancomycin is not susceptible to penicillinases because it does not work by targeting penicillin-binding proteins. This makes it effective against bacteria that produce \u03b2-lactamases, such as MRSA.</li><li>\u27a4 bactericidal</li><li>\u27a4 Gram-positive</li><li>\u27a4 poor oral bioavailability</li><li>\u27a4 not susceptible to penicillinases</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "79fdee31",
      "audio": ""
    },
    {
      "text": "Chemical structure of a drug is shown in the figure below. It is drug of choice for:",
      "options": [
        {
          "label": "A",
          "text": "Enteric fever",
          "correct": false
        },
        {
          "label": "B",
          "text": "Q fever",
          "correct": true
        },
        {
          "label": "C",
          "text": "MRSA penumonia",
          "correct": false
        },
        {
          "label": "D",
          "text": "P vivax malaria",
          "correct": false
        }
      ],
      "correct_answer": "B. Q fever",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-162205.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Q fever</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Doxycycline , a tetracycline antibiotic with a four-ring chemical structure, is the drug of choice for infections caused by intracellular organisms, such as Q fever (caused by Coxiella burnetii ). It is not the drug of choice for enteric fever, MRSA pneumonia, or P. vivax malaria.</li><li>\u27a4 Doxycycline , a tetracycline antibiotic with a four-ring chemical structure, is the drug of choice for infections caused by intracellular organisms, such as Q fever (caused by Coxiella burnetii ). It is not the drug of choice for enteric fever, MRSA pneumonia, or P. vivax malaria.</li><li>\u27a4 Doxycycline</li><li>\u27a4 Q fever</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "62ffe4a6",
      "audio": ""
    },
    {
      "text": "A 56-year-old male presents to the hospital with symptoms of fever, productive cough, and shortness of breath. His medical history includes recent surgery and prolonged hospitalization. A sputum culture reveals infection with Pseudomonas aeruginosa , and the infectious disease team decides to start treatment with a third-generation cephalosporin that has activity against Gram-negative bacteria, including Pseudomonas . Which of the following is a third-generation cephalosporin ?",
      "options": [
        {
          "label": "A",
          "text": "Cefoxitin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cefadroxil",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ceftazidime",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cefpirome",
          "correct": false
        }
      ],
      "correct_answer": "C. Ceftazidime",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Ceftazidime</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Third-generation cephalosporins, like ceftazidime , are widely used for their broad spectrum of activity against Gram-negative organisms, including Pseudomonas aeruginosa . They are more resistant to \u03b2-lactamases than earlier generations, making them useful in treating hospital-acquired infections</li><li>\u27a4 ceftazidime</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1fe67d0e",
      "audio": ""
    },
    {
      "text": "Which of the following drugs binds irreversibly to the site labelled as B in the given figure?",
      "options": [
        {
          "label": "A",
          "text": "Abciximab",
          "correct": false
        },
        {
          "label": "B",
          "text": "Prasugrel",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cangrelor",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vorapaxar",
          "correct": false
        }
      ],
      "correct_answer": "B. Prasugrel",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-162415.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Prasugrel</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Prasugrel is an irreversible P2Y12 receptor inhibitor used to reduce the risk of thrombotic events in patients with acute coronary syndrome. It permanently blocks ADP-mediated platelet activation. In contrast, other agents like Cangrelor provide reversible P2Y12 inhibition, and Abciximab and Vorapaxar target different mechanisms of platelet inhibition.</li><li>\u27a4 Prasugrel</li><li>\u27a4 Cangrelor</li><li>\u27a4 Abciximab</li><li>\u27a4 Vorapaxar</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e6b6389c",
      "audio": ""
    },
    {
      "text": "Which of the following statements about warfarin group of oral anticoagulants is false ?",
      "options": [
        {
          "label": "A",
          "text": "They interfere with an early step in the synthesis of clotting factors",
          "correct": true
        },
        {
          "label": "B",
          "text": "Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days",
          "correct": false
        },
        {
          "label": "C",
          "text": "Their dose is adjusted by repeated measurement of INR",
          "correct": false
        },
        {
          "label": "D",
          "text": "They are contraindicated during first trimester of pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "A. They interfere with an early step in the synthesis of clotting factors",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. They interfere with an early step in the synthesis of clotting factors</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 B. Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days</li><li>\u2022 B. Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days</li><li>\u2022 This statement is true. Warfarin has a delayed onset of action because it does not affect clotting factors that have already been synthesized and are present in the bloodstream. It takes several days for these existing clotting factors to degrade and for the anticoagulant effect to become apparent.</li><li>\u2022 C. Their dose is adjusted by repeated measurement of INR</li><li>\u2022 C. Their dose is adjusted by repeated measurement of INR</li><li>\u2022 This statement is true. The dose of warfarin is adjusted based on the International Normalized Ratio (INR) to ensure that the patient's blood is maintained within the therapeutic range, which minimizes the risk of bleeding and thromboembolism.</li><li>\u2022 D. They are contraindicated during first trimester of pregnancy</li><li>\u2022 D. They are contraindicated during first trimester of pregnancy</li><li>\u2022 This statement is true. Warfarin is contraindicated during pregnancy, especially in the first trimester, due to its teratogenic effects. It can cause fetal warfarin syndrome, characterized by nasal hypoplasia and stippled epiphyses, among other congenital abnormalities.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Warfarin is an oral anticoagulant that inhibits the enzyme vitamin K epoxide reductase, affecting the carboxylation and activation of certain clotting factors. It has a delayed onset of action, typically taking 4-5 days, and its dose is adjusted based on INR measurements. Warfarin is contraindicated during pregnancy due to its teratogenic potential, especially in the first trimester.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2a89253e",
      "audio": ""
    },
    {
      "text": "A 67-year-old female with atrial fibrillation is prescribed dabigatran, an oral direct thrombin inhibitor, for stroke prevention. A few months later, she is admitted to the emergency department with a gastrointestinal bleed. Which of the following drugs can be used to reverse the anticoagulant effect of dabigatran in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Idarucizumab",
          "correct": true
        },
        {
          "label": "B",
          "text": "Andexanet alpha",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vitamin K",
          "correct": false
        },
        {
          "label": "D",
          "text": "Protamine sulphate",
          "correct": false
        }
      ],
      "correct_answer": "A. Idarucizumab",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-163033.png"
      ],
      "explanation": "<p><strong>Ans. A) Idarucizumab</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "80f2d5cc",
      "audio": ""
    },
    {
      "text": "A 58-year-old male undergoing chemotherapy for lung cancer is being treated with cisplatin , a platinum-based chemotherapeutic agent. On the third day of his treatment cycle, he develops severe, intractable vomiting. Which of the following is the agent of choice for controlling this vomiting?",
      "options": [
        {
          "label": "A",
          "text": "Fosaprepitant",
          "correct": true
        },
        {
          "label": "B",
          "text": "Granisetron",
          "correct": false
        },
        {
          "label": "C",
          "text": "Metoclopramide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Domperidone",
          "correct": false
        }
      ],
      "correct_answer": "A. Fosaprepitant",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Fosaprepitant</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For chemotherapy-induced nausea and vomiting (CINV) , particularly with drugs like cisplatin that are highly emetogenic:</li><li>\u27a4 chemotherapy-induced nausea and vomiting (CINV)</li><li>\u27a4 cisplatin</li><li>\u27a4 Fosaprepitant (an NK1 receptor antagonist) is most effective for preventing delayed-phase vomiting . Granisetron and other 5-HT3 antagonists are more effective for acute-phase vomiting . Metoclopramide and domperidone are generally used for motility-related nausea but are not the first choice for CINV.</li><li>\u27a4 Fosaprepitant (an NK1 receptor antagonist) is most effective for preventing delayed-phase vomiting .</li><li>\u27a4 Fosaprepitant</li><li>\u27a4 delayed-phase vomiting</li><li>\u27a4 Granisetron and other 5-HT3 antagonists are more effective for acute-phase vomiting .</li><li>\u27a4 Granisetron</li><li>\u27a4 5-HT3 antagonists</li><li>\u27a4 acute-phase vomiting</li><li>\u27a4 Metoclopramide and domperidone are generally used for motility-related nausea but are not the first choice for CINV.</li><li>\u27a4 Metoclopramide</li><li>\u27a4 domperidone</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "83abf0ff",
      "audio": ""
    },
    {
      "text": "A 2-month pregnant female presented with Plasmodium vivax malaria. Which of the following is the appropriate treatment for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Chloroquine plus primaquine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Quinine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Artesunate plus sulfadoxine-pyrimethamine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Doxycycline",
          "correct": false
        }
      ],
      "correct_answer": "B. Quinine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "570a3cd1",
      "audio": ""
    },
    {
      "text": "A pregnant female who is a known case of bronchial asthma presented to hospital with blood pressure of 160/100 mm Hg. Which of the following is the preferred drug for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Oral Labetalol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intravenous Nicardipine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Oral Amlodipine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Oral Lisinopril",
          "correct": false
        }
      ],
      "correct_answer": "C. Oral Amlodipine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Oral Amlodipine</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For pregnant patients with both hypertension and asthma , calcium channel blockers like amlodipine are preferred because they are safe for both pregnancy and asthma management. Beta-blockers , like labetalol, can exacerbate bronchoconstriction and should be used cautiously in asthmatic patients.</li><li>\u27a4 hypertension</li><li>\u27a4 asthma</li><li>\u27a4 amlodipine</li><li>\u27a4 Beta-blockers</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e391f1e3",
      "audio": ""
    },
    {
      "text": "A 45-year-old male undergoing shoulder surgery receives a brachial plexus block with 0.5% lignocaine for anesthesia. Shortly after the procedure, the patient develops signs of severe hypotension and cardiovascular collapse. What is the most appropriate treatment for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Sodium bicarbonate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Norepinephrine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Atropine",
          "correct": false
        },
        {
          "label": "D",
          "text": "20% lipid emulsion therapy",
          "correct": true
        }
      ],
      "correct_answer": "D. 20% lipid emulsion therapy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) 20% lipid emulsion therapy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of local anesthetic systemic toxicity (LAST) , especially with agents like lignocaine and bupivacaine, 20% lipid emulsion therapy is the gold standard treatment to reverse the toxic effects on the cardiovascular and central nervous systems. Early recognition and prompt administration of lipid therapy can be life-saving in these scenarios.</li><li>\u27a4 local anesthetic systemic toxicity (LAST)</li><li>\u27a4 20% lipid emulsion therapy</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "935541d5",
      "audio": ""
    },
    {
      "text": "A 40-year-old obese female with schizophrenia is being considered for antipsychotic treatment. Which of the following antipsychotic drugs is associated with the least metabolic adverse effects?",
      "options": [
        {
          "label": "A",
          "text": "Haloperidol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Clozapine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Risperidone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Aripiprazole",
          "correct": true
        }
      ],
      "correct_answer": "D. Aripiprazole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Aripiprazole</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When treating patients with schizophrenia who are at risk of metabolic side effects, antipsychotics such as aripiprazole should be considered due to their lower likelihood of causing weight gain and other metabolic disturbances compared to drugs like clozapine or risperidone.</li><li>\u27a4 aripiprazole</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7d76f4c7",
      "audio": ""
    },
    {
      "text": "A 35-year-old female with a previous history of GTCS presents with convulsions which are ongoing since 25 minutes. What should be the appropriate management of this patient?",
      "options": [
        {
          "label": "A",
          "text": "Lorazepam followed by valproate",
          "correct": true
        },
        {
          "label": "B",
          "text": "Valproate followed by lamotrigine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ethosuximide followed by gabapentin.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Carbamazepine followed by phenytoin",
          "correct": false
        }
      ],
      "correct_answer": "A. Lorazepam followed by valproate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Lorazepam followed by valproate</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In status epilepticus , immediate control of seizures is critical. Lorazepam is the first-line agent for rapidly stopping seizures, and once the acute phase is managed, valproate can be used for long-term seizure prevention. Other agents like ethosuximide and carbamazepine are not suitable for this clinical scenario, as they either lack the rapid onset required or are not effective for generalized tonic-clonic seizures.</li><li>\u27a4 status epilepticus</li><li>\u27a4 Lorazepam</li><li>\u27a4 valproate</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d58734a5",
      "audio": ""
    },
    {
      "text": "A 58-year-old male with hypertension is on hydrochlorothiazide for blood pressure control. He presents with symptoms of fatigue, and lab results show hypokalemia. Which of the following drugs can be added to prevent the loss of potassium in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Furosemide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mannitol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Eplerenone",
          "correct": true
        },
        {
          "label": "D",
          "text": "Acetazolamide",
          "correct": false
        }
      ],
      "correct_answer": "C. Eplerenone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Eplerenone</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When patients on thiazide diuretics like hydrochlorothiazide develop hypokalemia , adding a potassium-sparing diuretic such as eplerenone can help prevent further potassium loss.</li><li>\u27a4 thiazide diuretics</li><li>\u27a4 hypokalemia</li><li>\u27a4 potassium-sparing diuretic</li><li>\u27a4 eplerenone</li><li>\u27a4 Furosemide and acetazolamide should be avoided, as they can exacerbate hypokalemia.</li><li>\u27a4 Furosemide</li><li>\u27a4 acetazolamide</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "03e7af88",
      "audio": ""
    },
    {
      "text": "What does it mean when a drug has an oral bioavailability of 20 percent?",
      "options": [
        {
          "label": "A",
          "text": "80 percent of the drug undergoes first pass metabolism in liver.",
          "correct": false
        },
        {
          "label": "B",
          "text": "20 percent of the drug is absorbed into portal circulation.",
          "correct": false
        },
        {
          "label": "C",
          "text": "The drug is 20 percent potent in producing therapeutic effect.",
          "correct": false
        },
        {
          "label": "D",
          "text": "20 percent of the drug reaches the systemic circulation in unchanged form",
          "correct": true
        }
      ],
      "correct_answer": "D. 20 percent of the drug reaches the systemic circulation in unchanged form",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) 30 percent of the drug reaches the systemic circulation in unchanged form</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Oral bioavailability is the proportion of a drug that reaches the systemic circulation in an unchanged form after oral administration. A drug with 20 percent oral bioavailability means that only 20 percent of the administered dose enters the bloodstream and is available for therapeutic action.</li><li>\u27a4 Oral bioavailability</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a2c42ab9",
      "audio": ""
    },
    {
      "text": "A 62-year-old post-menopausal woman is diagnosed with estrogen receptor-positive (ER+) breast cancer. She has no significant history of other health conditions. Which of the following is the preferred drug for the treatment of breast cancer in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Lapatinib",
          "correct": false
        },
        {
          "label": "B",
          "text": "Trastuzumab",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tamoxifen",
          "correct": false
        },
        {
          "label": "D",
          "text": "Letrozole",
          "correct": true
        }
      ],
      "correct_answer": "D. Letrozole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Letrozole</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For post-menopausal women with hormone receptor-positive breast cancer , letrozole (an aromatase inhibitor) is the preferred treatment. It reduces estrogen levels by inhibiting the aromatase enzyme, which is the primary source of estrogen in post-menopausal women. This helps to slow the growth of estrogen-dependent breast cancer. Tamoxifen is more commonly used in pre-menopausal women, while HER2-targeted therapies like trastuzumab and lapatinib are reserved for HER2-positive breast cancer.</li><li>\u27a4 hormone receptor-positive breast cancer</li><li>\u27a4 letrozole</li><li>\u27a4 Tamoxifen</li><li>\u27a4 HER2-targeted therapies</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "45427aed",
      "audio": ""
    },
    {
      "text": "A patient with history of HIV was started on anti-retroviral therapy consisting of lamivudine 300 mg, tenofovir 150 mg and efavirenz 600 mg once daily at night. Few weeks later, he developed tuberculosis and was started on anti-tubercular drugs. Which of the following dose adjustment may be required in this patient?",
      "options": [
        {
          "label": "A",
          "text": "No dose adjustment is required",
          "correct": true
        },
        {
          "label": "B",
          "text": "Add tenofovir 150 mg in the morning",
          "correct": false
        },
        {
          "label": "C",
          "text": "Add lamivudine 300 mg in the morning",
          "correct": false
        },
        {
          "label": "D",
          "text": "Add efavirenz 600 mg in the morning",
          "correct": false
        }
      ],
      "correct_answer": "A. No dose adjustment is required",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) No dose adjustment is required</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When treating patients with HIV who develop tuberculosis and are placed on rifampicin-containing therapy , no dose adjustments are required for efavirenz , lamivudine , or tenofovir . Despite rifampicin\u2019s potential to induce drug metabolism, the standard dosing of these antiretroviral medications remains effective according to current guidelines.</li><li>\u27a4 rifampicin-containing therapy</li><li>\u27a4 efavirenz</li><li>\u27a4 lamivudine</li><li>\u27a4 tenofovir</li><li>\u27a4 ADJUSTMENT OF ARV REGIMEN WITH CONCOMITANT ATT:</li><li>\u27a4 ADJUSTMENT OF ARV REGIMEN WITH CONCOMITANT ATT:</li><li>\u27a4 When a patient already on 2NRTIs + 1NNRTI (EFV)\u2013based regimen has to be given 2HRZE + 4HRE\u2013based ATT for the newly detected TB, same ART regimen can be continued without any modification. When a patient already on 2NRTIs + DTG\u2013based regimen has to be given Rifampicin-based ATT for the newly detected TB, same ART regimen can be continued. However, since co-administered rifampicin reduces bioavailability of DTG, which can be overcome by an additional tablet of DTG 50 mg (at an interval of 12 hours with the regular dose of DTG) till the completion of ATT. Once the ATT is completed, additional tablet of DTG 50 mg should be stopped 2 weeks after stoppage of Rifampicin-containing treatment regimen. When a patient already on 2NRTIs + PI\u2013based regimen develops TB, ART regimen has to be modified if 2HREZ + 4HRE\u2013based ATT is co-administered. If the patient has not taken DTG earlier, patient is shifted to 2 NRTIs + DLG-based regimen with twice daily DTG as discussed in last section If DLG cannot be given due to any reason and boosted PIs need to continued, then rifampicin should be replaced by rifabutin</li><li>\u27a4 When a patient already on 2NRTIs + 1NNRTI (EFV)\u2013based regimen has to be given 2HRZE + 4HRE\u2013based ATT for the newly detected TB, same ART regimen can be continued without any modification.</li><li>\u27a4 When a patient already on 2NRTIs + DTG\u2013based regimen has to be given Rifampicin-based ATT for the newly detected TB, same ART regimen can be continued. However, since co-administered rifampicin reduces bioavailability of DTG, which can be overcome by an additional tablet of DTG 50 mg (at an interval of 12 hours with the regular dose of DTG) till the completion of ATT. Once the ATT is completed, additional tablet of DTG 50 mg should be stopped 2 weeks after stoppage of Rifampicin-containing treatment regimen.</li><li>\u27a4 When a patient already on 2NRTIs + PI\u2013based regimen develops TB, ART regimen has to be modified if 2HREZ + 4HRE\u2013based ATT is co-administered. If the patient has not taken DTG earlier, patient is shifted to 2 NRTIs + DLG-based regimen with twice daily DTG as discussed in last section If DLG cannot be given due to any reason and boosted PIs need to continued, then rifampicin should be replaced by rifabutin</li><li>\u27a4 If the patient has not taken DTG earlier, patient is shifted to 2 NRTIs + DLG-based regimen with twice daily DTG as discussed in last section If DLG cannot be given due to any reason and boosted PIs need to continued, then rifampicin should be replaced by rifabutin</li><li>\u27a4 If the patient has not taken DTG earlier, patient is shifted to 2 NRTIs + DLG-based regimen with twice daily DTG as discussed in last section</li><li>\u27a4 If DLG cannot be given due to any reason and boosted PIs need to continued, then rifampicin should be replaced by rifabutin</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5af95e31",
      "audio": ""
    },
    {
      "text": "A 32-year-old male is brought to the emergency department after ingesting an overdose of a medication. In order to enhance drug clearance, you consider the modification of urinary pH as a therapeutic measure. Knowing that manipulating the urinary pH can increase the excretion of certain drugs by altering their ionization state, which of the following drugs would not have its excretion increased by alkalinization of the urine?",
      "options": [
        {
          "label": "A",
          "text": "Aspirin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Methotrexate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Morphine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Phenobarbitone",
          "correct": false
        }
      ],
      "correct_answer": "C. Morphine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Morphine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Aspirin : Aspirin (acetylsalicylic acid) is an acidic drug . Alkalinizing the urine with agents such as sodium bicarbonate can enhance its ionization and excretion.</li><li>\u2022 Option A.</li><li>\u2022 Aspirin</li><li>\u2022 Aspirin</li><li>\u2022 acidic drug</li><li>\u2022 Option B. Methotrexate : This is also an acidic drug , and alkalinization of the urine will increase its ionization , decreasing reabsorption and increasing elimination.</li><li>\u2022 Option B.</li><li>\u2022 Methotrexate</li><li>\u2022 acidic drug</li><li>\u2022 alkalinization of the urine will increase its ionization</li><li>\u2022 Option D. Phenobarbitone : This is an acidic drug , and like aspirin and methotrexate , it is more ionized in alkaline urine, leading to increased excretion.</li><li>\u2022 Option D.</li><li>\u2022 Phenobarbitone</li><li>\u2022 acidic drug</li><li>\u2022 aspirin and methotrexate</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cases of drug overdose , urinary alkalinization is utilized to increase the excretion of acidic drugs by enhancing their ionization , which does not apply to basic drugs like morphine that are better excreted in acidic conditions. Remember, the drugs ending with \u2018ine\u2019 are basic.</li><li>\u27a4 drug overdose</li><li>\u27a4 urinary alkalinization</li><li>\u27a4 increase the excretion of acidic drugs</li><li>\u27a4 enhancing their ionization</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fb3f780d",
      "audio": ""
    },
    {
      "text": "The volume of distribution of a drug is 100 L and the clearance is 50 L/hour and target plasma concentration of drug required is 0.5 mg/L. The drug needs to be given twice a day. What will be the maintenance dose of this drug?",
      "options": [
        {
          "label": "A",
          "text": "50 mg",
          "correct": false
        },
        {
          "label": "B",
          "text": "25 mg",
          "correct": false
        },
        {
          "label": "C",
          "text": "300 mg",
          "correct": true
        },
        {
          "label": "D",
          "text": "600 mg",
          "correct": false
        }
      ],
      "correct_answer": "C. 300 mg",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.\u00a0C) 300 mg</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c2941db3",
      "audio": ""
    },
    {
      "text": "Which of the following drugs acts via the receptor show in figure?",
      "options": [
        {
          "label": "A",
          "text": "Aldosterone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Insulin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sumatriptan",
          "correct": true
        },
        {
          "label": "D",
          "text": "Nicotine",
          "correct": false
        }
      ],
      "correct_answer": "C. Sumatriptan",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-165457.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Sumatriptan</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sumatriptan acts via GPCRs , specifically the 5-HT1 receptor , which plays a key role in treating migraines. Other molecules like aldosterone, insulin, and nicotine act through different receptor pathways, such as nuclear receptors, tyrosine kinase receptors, or ion channels, respectively.</li><li>\u27a4 Sumatriptan</li><li>\u27a4 GPCRs</li><li>\u27a4 5-HT1 receptor</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5f6c1975",
      "audio": ""
    },
    {
      "text": "Log DRC of four drugs is shown in the given diagram. Which of the following statements is correct about these drugs?",
      "options": [
        {
          "label": "A",
          "text": "Drug B is the most efficacious.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Drug D is more potent than drug C",
          "correct": false
        },
        {
          "label": "C",
          "text": "Drug A and Drug C have same potency",
          "correct": false
        },
        {
          "label": "D",
          "text": "Drug A is more efficacious than drug B",
          "correct": true
        }
      ],
      "correct_answer": "D. Drug A is more efficacious than drug B",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-165724.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Drug A is more efficacious than drug B</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In dose-response curves:</li><li>\u27a4 Efficacy is determined by the height of the curve (how much response the drug can produce). Potency is determined by the position of the curve along the x-axis (lower doses indicate higher potency). In the diagram, Drug A is more efficacious than Drug B , and Drug C is more potent than Drug D .</li><li>\u27a4 Efficacy is determined by the height of the curve (how much response the drug can produce).</li><li>\u27a4 Efficacy</li><li>\u27a4 height</li><li>\u27a4 Potency is determined by the position of the curve along the x-axis (lower doses indicate higher potency). In the diagram, Drug A is more efficacious than Drug B , and Drug C is more potent than Drug D .</li><li>\u27a4 Potency</li><li>\u27a4 position</li><li>\u27a4 Drug A</li><li>\u27a4 Drug B</li><li>\u27a4 Drug C</li><li>\u27a4 Drug D</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3f235cf6",
      "audio": ""
    },
    {
      "text": "Which of the following acts on \u03b11, \u03b12 and \u03b21 receptors but does not stimulate \u03b22 receptors?",
      "options": [
        {
          "label": "A",
          "text": "Adrenaline",
          "correct": false
        },
        {
          "label": "B",
          "text": "Noradrenaline",
          "correct": true
        },
        {
          "label": "C",
          "text": "Isoprenaline",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dobutamine",
          "correct": false
        }
      ],
      "correct_answer": "B. Noradrenaline",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-115834.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Noradrenaline</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Noradrenaline (norepinephrine) acts on \u03b11, \u03b12, and \u03b21 adrenergic receptors. It is a naturally occurring catecholamine that functions as a neurotransmitter and hormone in the body . Noradrenaline's action on \u03b11 and \u03b12 receptors is responsible for its vasoconstrictive effects , while its action on \u03b21 receptors affects cardiac output by increasing the heart rate and myocardial contractility. It does not stimulate \u03b22 receptors , which are primarily involved in bronchodilation and vasodilation .</li><li>\u2022 Noradrenaline (norepinephrine) acts on \u03b11, \u03b12, and \u03b21 adrenergic receptors.</li><li>\u2022 catecholamine</li><li>\u2022 neurotransmitter and hormone in the body</li><li>\u2022 \u03b11 and \u03b12 receptors</li><li>\u2022 vasoconstrictive effects</li><li>\u2022 \u03b21 receptors</li><li>\u2022 cardiac output by increasing the heart rate</li><li>\u2022 myocardial</li><li>\u2022 contractility.</li><li>\u2022 does not stimulate \u03b22 receptors</li><li>\u2022 bronchodilation and vasodilation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f21c814d",
      "audio": ""
    },
    {
      "text": "A child on formoterol inhaler for treatment of bronchial asthma may exhibit all of the following features except?",
      "options": [
        {
          "label": "A",
          "text": "Tremors",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypoglycemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hypokalemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypotension",
          "correct": false
        }
      ],
      "correct_answer": "B. Hypoglycemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Hypoglycemia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Long-acting \u03b22-agonists (LABAs) like formoterol can cause side effects such as tremors , hypokalemia , and hypotension due to their activation of \u03b22-adrenergic receptors. However, they are not typically associated with hypoglycemia , as \u03b22-agonists tend to increase blood glucose levels.</li><li>\u27a4 formoterol</li><li>\u27a4 tremors</li><li>\u27a4 hypokalemia</li><li>\u27a4 hypotension</li><li>\u27a4 hypoglycemia</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a7d8dd8d",
      "audio": ""
    },
    {
      "text": "A patient of septic shock was given intravenous nor-epinephrine. The response to this drug is best checked by?",
      "options": [
        {
          "label": "A",
          "text": "Increase in heart rate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decrease in heart rate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase in mean arterial pressure",
          "correct": true
        },
        {
          "label": "D",
          "text": "Decreased renal perfusion and reduced urine output",
          "correct": false
        }
      ],
      "correct_answer": "C. Increase in mean arterial pressure",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Increase in mean arterial pressure</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Increase in heart rate - Not the best indicator for the efficacy of nor-epinephrine in septic shock , as the drug may actually lead to a reflex bradycardia due to increased blood pressure.</li><li>\u2022 Option A. Increase in heart rate</li><li>\u2022 Not the best indicator</li><li>\u2022 nor-epinephrine in septic shock</li><li>\u2022 reflex bradycardia due to increased blood pressure.</li><li>\u2022 Option B. Decrease in heart rate - While nor-epinephrine can cause a reflex decrease in heart rate due to increased blood pressure, it's not the primary indicator of therapeutic response in septic shock.</li><li>\u2022 Option B. Decrease in heart rate</li><li>\u2022 nor-epinephrine</li><li>\u2022 reflex decrease in heart rate</li><li>\u2022 increased blood pressure,</li><li>\u2022 not the primary indicator</li><li>\u2022 Option D. Decreased renal perfusion and reduced urine output - These are potential adverse effects of nor-epinephrine due to its vasoconstrictive action , not indicators of a positive therapeutic response.</li><li>\u2022 Option D. Decreased renal perfusion and reduced urine output</li><li>\u2022 potential adverse effects of nor-epinephrine</li><li>\u2022 vasoconstrictive action</li><li>\u2022 not</li><li>\u2022 positive therapeutic response.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The effectiveness of nor-epinephrine in the management of septic shock is best monitored by an increase in mean arterial pressure , aiming to maintain a mean BP above 70 mm Hg and systolic BP above 90 mm Hg to ensure adequate organ perfusion .</li><li>\u2022 nor-epinephrine</li><li>\u2022 septic shock</li><li>\u2022 monitored</li><li>\u2022 increase in mean arterial pressure</li><li>\u2022 maintain a mean BP above 70 mm Hg and systolic BP above 90 mm Hg</li><li>\u2022 adequate organ perfusion</li><li>\u2022 Ref: Harrison 19 th /1761</li><li>\u2022 Ref:</li><li>\u2022 Harrison 19 th /1761</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3c827603",
      "audio": ""
    },
    {
      "text": "Which of the following patients would not benefit from the use of beta blockers?",
      "options": [
        {
          "label": "A",
          "text": "64-year-old female with frequent attacks of migraine",
          "correct": false
        },
        {
          "label": "B",
          "text": "35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors",
          "correct": false
        },
        {
          "label": "C",
          "text": "56-year-old male with erectile dysfunction",
          "correct": true
        },
        {
          "label": "D",
          "text": "74-year-old male with history of compensated heart failure",
          "correct": false
        }
      ],
      "correct_answer": "C. 56-year-old male with erectile dysfunction",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) 56-year-old male with erectile dysfunction</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. 64-year-old female with frequent attacks of migraine: Beta-blockers are often used for the prophylaxis of migraines . They can help reduce the frequency and severity of migraine attacks.</li><li>\u2022 Option A. 64-year-old female with frequent attacks of migraine: Beta-blockers are often used for the prophylaxis of migraines . They can help reduce the frequency and severity of migraine attacks.</li><li>\u2022 Option A. 64-year-old female with frequent attacks of migraine:</li><li>\u2022 Beta-blockers</li><li>\u2022 prophylaxis of</li><li>\u2022 migraines</li><li>\u2022 reduce the frequency</li><li>\u2022 severity of migraine attacks.</li><li>\u2022 Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors: Beta-blockers are useful in managing symptoms of hyperthyroidism such as tachycardia and tremors by blocking the effects of excess t hyroid hormones on the heart and other tissues.</li><li>\u2022 Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors: Beta-blockers are useful in managing symptoms of hyperthyroidism such as tachycardia and tremors by blocking the effects of excess t hyroid hormones on the heart and other tissues.</li><li>\u2022 Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors:</li><li>\u2022 Beta-blockers</li><li>\u2022 useful</li><li>\u2022 hyperthyroidism</li><li>\u2022 tachycardia and tremors</li><li>\u2022 blocking the effects</li><li>\u2022 excess</li><li>\u2022 hyroid hormones on the heart and other tissues.</li><li>\u2022 Option D. 74-year-old male with history of compensated heart failure: Certain beta-blockers are indicated in the management of heart failure . They can i mprove survival and reduce the need for hospitalization in patients with heart failure, especially those with a history of compensated heart failure, provided they are carefully selected and dosed.</li><li>\u2022 Option D. 74-year-old male with history of compensated heart failure: Certain beta-blockers are indicated in the management of heart failure . They can i mprove survival and reduce the need for hospitalization in patients with heart failure, especially those with a history of compensated heart failure, provided they are carefully selected and dosed.</li><li>\u2022 Option D. 74-year-old male with history of compensated heart failure:</li><li>\u2022 beta-blockers</li><li>\u2022 heart failure</li><li>\u2022 mprove survival and reduce</li><li>\u2022 hospitalization</li><li>\u2022 heart</li><li>\u2022 failure,</li><li>\u2022 history of compensated heart failure,</li><li>\u2022 carefully selected and dosed.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The objective is to understand the indications and contraindications for beta-blocker therapy . While beta-blockers are versatile medications with a broad range of clinical applications , their potential side effects, such as exacerbating erectile dysfunction , must be considered when prescribing these drugs to ensure they align with the patient's overall health status and medical needs.</li><li>\u27a4 indications and contraindications</li><li>\u27a4 beta-blocker therapy</li><li>\u27a4 beta-blockers are versatile</li><li>\u27a4 medications</li><li>\u27a4 broad range of clinical applications</li><li>\u27a4 potential side effects,</li><li>\u27a4 exacerbating erectile dysfunction</li><li>\u27a4 prescribing these drugs to ensure they align</li><li>\u27a4 health status and medical needs.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ba251c9b",
      "audio": ""
    },
    {
      "text": "All the following are contraindications for the use of metformin except?",
      "options": [
        {
          "label": "A",
          "text": "Hypotensive state",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alcoholics",
          "correct": false
        },
        {
          "label": "C",
          "text": "Renal failure",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypokalemia",
          "correct": true
        }
      ],
      "correct_answer": "D. Hypokalemia",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture1.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Hypokalemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hypotensive state : While not a direct contraindication, caution is advised in conditions that may predispose patients to hypotension , as low perfusion may increase the risk of metformin induced lactic acidosis.</li><li>\u2022 Option A. Hypotensive state</li><li>\u2022 not a direct contraindication,</li><li>\u2022 predispose patients to hypotension</li><li>\u2022 low perfusion</li><li>\u2022 increase the risk of metformin</li><li>\u2022 lactic acidosis.</li><li>\u2022 Option B. Alcoholics : Chronic and excessive alcohol consumption is a contraindication for metformin use due to the increased risk of lactic acidosis , especially in cases of hepatic impairment and acute alcohol intoxication.</li><li>\u2022 Option B. Alcoholics</li><li>\u2022 Chronic and excessive alcohol</li><li>\u2022 contraindication for metformin</li><li>\u2022 increased risk of lactic acidosis</li><li>\u2022 hepatic impairment and acute alcohol intoxication.</li><li>\u2022 Option C. Renal failure : Renal failure or significant renal impairment is a contraindication for the use of metformin due to the increased risk of accumulating metformin and subsequent lactic acidosis . Latest guidelines regarding use of metformin in renal dysfunction include:</li><li>\u2022 Option C. Renal failure</li><li>\u2022 renal impairment is a contraindication</li><li>\u2022 metformin</li><li>\u2022 increased risk of accumulating metformin</li><li>\u2022 lactic acidosis</li><li>\u2022 metformin in renal dysfunction</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Risk factors for metformin induced lactic acidosis :</li><li>\u27a4 Risk factors for metformin induced lactic acidosis</li><li>\u27a4 :</li><li>\u27a4 Hepatic failure Renal failure Alcoholics Metabolic acidosis Elderly Conditions predisposing to hypoxia (Shock, CHF, Severe anemia, Major surgery etc.)</li><li>\u27a4 Hepatic failure</li><li>\u27a4 Renal failure</li><li>\u27a4 Alcoholics</li><li>\u27a4 Metabolic acidosis</li><li>\u27a4 Elderly</li><li>\u27a4 Conditions predisposing to hypoxia (Shock, CHF, Severe anemia, Major surgery etc.)</li><li>\u27a4 Mnemonic:</li><li>\u27a4 Mnemonic:</li><li>\u27a4 MET: MET abolic acidosis</li><li>\u27a4 MET: MET</li><li>\u27a4 F: F ailure (Liver and Renal failure)</li><li>\u27a4 F: F</li><li>\u27a4 O R MIN: O xygen R eaching the tissues is MIN imum (means hypoxia causing conditions)</li><li>\u27a4 O R MIN: O</li><li>\u27a4 R</li><li>\u27a4 MIN</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1152b628",
      "audio": ""
    },
    {
      "text": "An obese diabetic patient was on metformin monotherapy, but his sugar levels were not well controlled. He does not comply with injectable drugs. He has a history of pancreatitis, and family history of bladder carcinoma. In view of the raised glucose levels, you wish to add another anti-diabetic drug. He does not comply with injectable drugs. Which one would you prefer?",
      "options": [
        {
          "label": "A",
          "text": "Exenatide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vildagliptin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Empagliflozin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pioglitazone",
          "correct": false
        }
      ],
      "correct_answer": "C. Empagliflozin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Empagliflozin</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d71d99f9",
      "audio": ""
    },
    {
      "text": "The given figure shows the mechanism of action of Drug Y in treatment of osteoporosis. Which of the following best represents drug Y?",
      "options": [
        {
          "label": "A",
          "text": "Raloxifene",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bisphosphonates",
          "correct": false
        },
        {
          "label": "C",
          "text": "Teriparatide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Denosumab",
          "correct": true
        }
      ],
      "correct_answer": "D. Denosumab",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture16.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Denosumab</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Raloxifene: Incorrect for this mechanism. Raloxifene is a selective estrogen receptor modulator (SERM) that mimics estrogen's bone-protective effect s by reducing osteoclast activity, but it does not work by targeting the RANKL-RANK interaction.</li><li>\u2022 Option A. Raloxifene:</li><li>\u2022 Incorrect</li><li>\u2022 Raloxifene is a selective estrogen receptor modulator (SERM)</li><li>\u2022 estrogen's bone-protective effect</li><li>\u2022 reducing osteoclast activity,</li><li>\u2022 does not</li><li>\u2022 RANKL-RANK interaction.</li><li>\u2022 Option B. Bisphosphonates: Also incorrect. Bisphosphonates inhibit osteoclast-mediated bone resorption by inducing osteoclast apoptosis and interfering with the mevalonate pathway , not by RANKL inhibition.</li><li>\u2022 Option B. Bisphosphonates:</li><li>\u2022 incorrect.</li><li>\u2022 inhibit</li><li>\u2022 osteoclast-mediated bone resorption</li><li>\u2022 osteoclast</li><li>\u2022 apoptosis</li><li>\u2022 mevalonate pathway</li><li>\u2022 Option C. Teriparatide: Incorrect for this illustration. Teriparatide, a recombinant form of parathyroid hormone , primarily works by stimulating osteoblasts to promote bone formation rather than inhibiting osteoclasts.</li><li>\u2022 Option C. Teriparatide:</li><li>\u2022 Incorrect</li><li>\u2022 Teriparatide,</li><li>\u2022 parathyroid hormone</li><li>\u2022 stimulating osteoblasts</li><li>\u2022 bone formation rather than inhibiting osteoclasts.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Denosumab is used in the treatment of osteoporosis by targeting the RANKL-RANK interaction , effectively inhibiting osteoclast formation and activity, thus decreasing bone resorption.</li><li>\u27a4 Denosumab</li><li>\u27a4 osteoporosis by targeting the RANKL-RANK interaction</li><li>\u27a4 inhibiting osteoclast</li><li>\u27a4 decreasing bone resorption.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9ce43baf",
      "audio": ""
    },
    {
      "text": "A 35-year-old patient presents to the clinic with a history of seizures. The patient is diagnosed with epilepsy and started on vigabatrin therapy. Which of the following statements is false about vigabatrin?",
      "options": [
        {
          "label": "A",
          "text": "Vigabatrin can cause visual field defect.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vigabatrin can be used in the treatment of infantile spasms.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vigabatrin is a GABA transaminase inhibitor.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vigabatrin is a first-line drug for absence seizures.",
          "correct": true
        }
      ],
      "correct_answer": "D. Vigabatrin is a first-line drug for absence seizures.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) \u00a0Vigabatrin is a first-line drug for absence seizures</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vigabatrin is not indicated for absence seizures and is primarily used for conditions such as infantile spasms and refractory epilepsy . It works by inhibiting GABA transaminase , increasing GABA levels in the brain, but carries a significant risk of visual field defects . The first-line drugs for absence seizures are typically ethosuximide or valproic acid .</li><li>\u27a4 Vigabatrin</li><li>\u27a4 absence seizures</li><li>\u27a4 infantile spasms</li><li>\u27a4 refractory epilepsy</li><li>\u27a4 GABA transaminase</li><li>\u27a4 visual field defects</li><li>\u27a4 ethosuximide</li><li>\u27a4 valproic acid</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "81f9c314",
      "audio": ""
    },
    {
      "text": "A patient of schizophrenia was prescribed haloperidol. Next day, he presented to the hospital with the features shown in the figure. What should be the treatment?",
      "options": [
        {
          "label": "A",
          "text": "Give propranolol.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increase dose of haloperidol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Reassurance",
          "correct": false
        },
        {
          "label": "D",
          "text": "Give benzhexol.",
          "correct": true
        }
      ],
      "correct_answer": "D. Give benzhexol.",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/picture6.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-164806.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Give benzhexol.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 This figure shows torticollis . It is an acute muscular dystonia , an extrapyramidal side effect of typical antipsychotics. This can appear within a few hours after the administration of antipsychotic drugs . Extrapyramidal side effects are seen more commonly with the use of high potency drugs like haloperidol and fluphenazine. Benzhexol is the drug of choice for acute muscular dystonia.</li><li>\u2022 This figure shows torticollis . It is an acute muscular dystonia , an extrapyramidal side effect of typical antipsychotics.</li><li>\u2022 torticollis</li><li>\u2022 acute muscular dystonia</li><li>\u2022 extrapyramidal side effect of typical antipsychotics.</li><li>\u2022 This can appear within a few hours after the administration of antipsychotic drugs .</li><li>\u2022 can</li><li>\u2022 within a few hours</li><li>\u2022 administration of antipsychotic drugs</li><li>\u2022 Extrapyramidal side effects are seen more commonly with the use of high potency drugs like haloperidol and fluphenazine.</li><li>\u2022 Extrapyramidal side effects</li><li>\u2022 more</li><li>\u2022 use of high potency</li><li>\u2022 haloperidol and fluphenazine.</li><li>\u2022 Benzhexol is the drug of choice for acute muscular dystonia.</li><li>\u2022 Benzhexol</li><li>\u2022 drug of choice</li><li>\u2022 acute muscular dystonia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "92589b12",
      "audio": ""
    },
    {
      "text": "This figure represents the mechanism of drugs used in the treatment of Parkinsonism. Which of the following statement about these drugs is incorrect?",
      "options": [
        {
          "label": "A",
          "text": "Drug A is the first line drug for treatment of Parkinsonism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Drug B can be entacapone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Drug C can cause cheese reaction",
          "correct": true
        },
        {
          "label": "D",
          "text": "Drug D decrease the peripheral adverse effects of levo-dopa",
          "correct": false
        }
      ],
      "correct_answer": "C. Drug C can cause cheese reaction",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-170712.png"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-170753.png"
      ],
      "explanation": "<p><strong>Ans. C) Drug C can cause a cheese reaction</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "91d6d667",
      "audio": ""
    },
    {
      "text": "A 28-year-old female patient with a history of asthma presents to the clinic with worsening shortness of breath, cough, and wheezing. Her asthma is typically well-controlled with inhaled glucocorticoids and short-acting beta-2 agonists as needed, but she reports increased symptoms over the past several days. The patient is started on montelukast as an adjunct therapy. What is the mechanism of action of montelukast?",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of leukotriene D4 receptor",
          "correct": true
        },
        {
          "label": "B",
          "text": "Inhibition of 5-lipoxygenase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Antagonism of muscarinic receptors",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inhibition of phosphodiesterase",
          "correct": false
        }
      ],
      "correct_answer": "A. Inhibition of leukotriene D4 receptor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Inhibition of leukotriene D4 receptor.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Inhibition of 5-lipoxygenase: This is the action of drugs like zileuton , not montelukast, and involves stopping leukotriene synthesis at an earlier stage in the pathway.</li><li>\u2022 Option B. Inhibition of 5-lipoxygenase:</li><li>\u2022 action of drugs like zileuton</li><li>\u2022 stopping leukotriene</li><li>\u2022 synthesis</li><li>\u2022 Option C. Antagonism of muscarinic receptors: Typically associated with anticholinergic drugs like ipratropium , which are used to relax airway smooth muscles via a different mechanism.</li><li>\u2022 Option C. Antagonism of muscarinic receptors:</li><li>\u2022 anticholinergic drugs like ipratropium</li><li>\u2022 relax airway smooth muscles</li><li>\u2022 different mechanism.</li><li>\u2022 Option D. Inhibition of phosphodiesterase: Associated with drugs like theophylline , which increase cAMP levels in smooth muscle cells, leading to bronchodilation.</li><li>\u2022 Option D. Inhibition of phosphodiesterase:</li><li>\u2022 theophylline</li><li>\u2022 increase cAMP levels</li><li>\u2022 smooth muscle</li><li>\u2022 cells, leading to bronchodilation.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Montelukast blocks leukotriene D4 receptors, crucial for managing chronic asthma and preventing exercise-induced bronchospasm. This mechanism highlights its role beyond immediate symptom relief, focusing on long-term asthma control.</li><li>\u27a4 Montelukast blocks leukotriene D4 receptors,</li><li>\u27a4 chronic asthma and preventing exercise-induced bronchospasm.</li><li>\u27a4 immediate symptom relief, focusing on long-term asthma control.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f7c930c8",
      "audio": ""
    },
    {
      "text": "A 45-year-old individual with no significant past medical history presents to the emergency department with fever, malaise, and a new heart murmur. Blood cultures are drawn, and the results reveal Streptococcus viridans, indicating a diagnosis of streptococcal endocarditis. The patient is started on penicillin therapy but develops hives, pruritus, and respiratory distress within minutes of the first dose, suggesting an immediate hypersensitivity reaction to penicillin. Which of the following is an alternative drug that can be used to manage streptococcal endocarditis in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Ceftriaxone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vancomycin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Meropenem",
          "correct": false
        },
        {
          "label": "D",
          "text": "Aztreonam",
          "correct": false
        }
      ],
      "correct_answer": "B. Vancomycin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Vancomycin</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For the treatment of streptococcal endocarditis in patients with a history of severe penicillin allergy , such as anaphylaxis, vancomycin is the preferred alternative due to its efficacy against Gram-positive bacteria and lack of cross-reactivity with \u03b2-lactam antibiotics. Cephalosporins, carbapenems, and monobactams are not recommended due to the potential for allergic reactions and/or their ineffectiveness against Gram-positive organisms like Streptococcus viridans.</li><li>\u27a4 streptococcal endocarditis</li><li>\u27a4 penicillin allergy</li><li>\u27a4 vancomycin</li><li>\u27a4 Gram-positive bacteria</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e5b560b2",
      "audio": ""
    },
    {
      "text": "All the following drugs are effective against MRSA EXCEPT.",
      "options": [
        {
          "label": "A",
          "text": "Vancomycin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cefoperazone",
          "correct": true
        },
        {
          "label": "C",
          "text": "Rifampicin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Linezolide",
          "correct": false
        }
      ],
      "correct_answer": "B. Cefoperazone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Cefoperazone</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Most \u03b2-lactam antibiotics (except for a few, like ceftaroline ) are ineffective against MRSA . Vancomycin , rifampicin , and linezolid are effective treatments for MRSA, but cefoperazone , as a third-generation cephalosporin, does not cover MRSA due to the altered PBPs that confer resistance.</li><li>\u27a4 \u03b2-lactam antibiotics</li><li>\u27a4 ceftaroline</li><li>\u27a4 ineffective</li><li>\u27a4 MRSA</li><li>\u27a4 Vancomycin</li><li>\u27a4 rifampicin</li><li>\u27a4 linezolid</li><li>\u27a4 cefoperazone</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7fb6225b",
      "audio": ""
    },
    {
      "text": "A patient presents with chronic cough since 3 months that is not responding to anitbiotics. The investigations confirms it to be a case of tuberculosis. Mycobacterium in this patient was found to be resistant to isoniazid, rifampicin, levofloxacin and linezolide. Which type of drug resistance it can be classified as?",
      "options": [
        {
          "label": "A",
          "text": "Multiple Drug Resistance Tuberculosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pre-Extensive Drug Resistance Tuberculosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Extremely Drug Resistance Tuberculosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Extensive Drug Resistance Tuberculosis",
          "correct": true
        }
      ],
      "correct_answer": "D. Extensive Drug Resistance Tuberculosis",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-173211.png"
      ],
      "explanation": "<p><strong>Ans. D) Extensive Drug Resistance Tuberculosis</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d8013c4f",
      "audio": ""
    },
    {
      "text": "A 7-year-old child is started on chemotherapy. One of the medications used in the treatment is L-asparaginase. This drug works by depleting asparagine, an amino acid that is required for the growth and survival of leukemia cells. Which of the following cancers is L-asparaginase commonly used to treat?",
      "options": [
        {
          "label": "A",
          "text": "Acute lymphoblastic leukemia (ALL)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Acute Myeloblastic Leukemia (AML)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chronic lymphocyctic leukemia (CLL)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chronic Myelocytic Leukemia (CML)",
          "correct": false
        }
      ],
      "correct_answer": "A. Acute lymphoblastic leukemia (ALL)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Acute lymphoblastic leukemia (ALL)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Acute Myeloblastic Leukemia (AML): AML is another type of leukemia but primarily affects different lineages of cells within the bone marrow . L-asparaginase is not typically used in the treatment of AML.</li><li>\u2022 Option B. Acute Myeloblastic Leukemia (AML):</li><li>\u2022 type of leukemia</li><li>\u2022 different lineages of cells</li><li>\u2022 bone marrow</li><li>\u2022 L-asparaginase</li><li>\u2022 not</li><li>\u2022 used</li><li>\u2022 AML.</li><li>\u2022 Option C. Chronic lymphocytic leukemia (CLL): CLL progresses more slowly than ALL and generally affects older adults. It is not treated with L-asparaginase.</li><li>\u2022 Option C. Chronic lymphocytic leukemia (CLL):</li><li>\u2022 progresses</li><li>\u2022 more slowly than ALL</li><li>\u2022 older adults.</li><li>\u2022 not</li><li>\u2022 L-asparaginase.</li><li>\u2022 Option D. Chronic Myelocytic Leukemia (CML): CML is a chronic form of leukemia affecting primarily adults . L-asparaginase is not effective against CML cells as they do not rely on external sources of asparagine like ALL cells.</li><li>\u2022 Option D. Chronic Myelocytic Leukemia (CML):</li><li>\u2022 chronic form of leukemia</li><li>\u2022 adults</li><li>\u2022 L-asparaginase</li><li>\u2022 not</li><li>\u2022 against CML cells</li><li>\u2022 do not</li><li>\u2022 external sources of asparagine</li><li>\u2022 ALL cells.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 L-asparaginase is particularly significant in the treatment of acute lymphoblastic leukemia (ALL) due to its unique mechanism of depleting asparagine , which is essential for the survival of ALL cells . This makes it a key component of chemotherapy regimens for ALL, especially in pediatric patients , where it can be combined with other drugs to enhance treatment efficacy and manage the disease effectively.</li><li>\u27a4 L-asparaginase</li><li>\u27a4 treatment of acute lymphoblastic leukemia (ALL)</li><li>\u27a4 depleting asparagine</li><li>\u27a4 essential for the survival of ALL cells</li><li>\u27a4 key component</li><li>\u27a4 chemotherapy regimens</li><li>\u27a4 ALL,</li><li>\u27a4 pediatric patients</li><li>\u27a4 combined with other drugs</li><li>\u27a4 treatment efficacy and</li><li>\u27a4 disease effectively.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a48d2ebc",
      "audio": ""
    },
    {
      "text": "Drug of choice for treatment of hypothyroidism in first trimester of pregnancy is:",
      "options": [
        {
          "label": "A",
          "text": "Propylthiouracil",
          "correct": false
        },
        {
          "label": "B",
          "text": "Carbimazole",
          "correct": false
        },
        {
          "label": "C",
          "text": "L-thyroxine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Radioactive iodine",
          "correct": false
        }
      ],
      "correct_answer": "C. L-thyroxine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) L-thyroxine</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The drug of choice for treating hypothyroidism during pregnancy, including the first trimester, is L-thyroxine (levothyroxine) . It is essential for maintaining normal thyroid hormone levels to ensure proper fetal development. Other drugs like Propylthiouracil and Carbimazole are used to treat hyperthyroidism, not hypothyroidism, and radioactive iodine is contraindicated in pregnancy.</li><li>\u27a4 L-thyroxine (levothyroxine)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "057b662d",
      "audio": ""
    },
    {
      "text": "A 35-year-old female with a history of epilepsy is being evaluated for her response to a new antiepileptic medication. The physician decides to review the dose-response characteristics of the drug to determine the optimal therapeutic dose. The drug's efficacy and safety were assessed using a quantal dose-response curve (DRC) during clinical trials. Which of the following statements best describes the quantal dose-response curve (DRC)?",
      "options": [
        {
          "label": "A",
          "text": "A quantal DRC measures the intensity of a drug's effect in a single patient at different doses.",
          "correct": false
        },
        {
          "label": "B",
          "text": "A quantal DRC plots the cumulative percentage of a population that exhibits a specified all-or-none effect (e.g., seizure prevention) at different doses.",
          "correct": true
        },
        {
          "label": "C",
          "text": "A quantal DRC is used to determine the dose at which 50% of an individual patient's maximum response is achieved.",
          "correct": false
        },
        {
          "label": "D",
          "text": "A quantal DRC assesses the relationship between drug concentration and response in a continuous manner for each individual.",
          "correct": false
        }
      ],
      "correct_answer": "B. A quantal DRC plots the cumulative percentage of a population that exhibits a specified all-or-none effect (e.g., seizure prevention) at different doses.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) A quantal DRC plots the cumulative percentage of a population that exhibits a specified all-or-none effect (e.g., seizure prevention) at different doses.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Understand that a quantal dose-response curve (DRC) represents the cumulative percentage of a population exhibiting a specified all-or-none effect at varying doses. It is used to determine important pharmacological parameters like the median effective dose (ED50), which is the dose at which 50% of the population achieves the desired therapeutic effect.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "194f6db7",
      "audio": ""
    },
    {
      "text": "A 54-year-old male with a history of chronic kidney disease (CKD) stage 4 presents with symptoms of fatigue, pallor, and shortness of breath. Laboratory investigations reveal hemoglobin levels of 8.5 g/dL (normal range: 13.8 to 17.2 g/dL in males), indicating anemia of CKD. Which of the following oral drugs can be used to treat anemia in this patient with CKD?",
      "options": [
        {
          "label": "A",
          "text": "Daprodustat",
          "correct": true
        },
        {
          "label": "B",
          "text": "Erythropoietin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Filgrastim",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oprelvekin",
          "correct": false
        }
      ],
      "correct_answer": "A. Daprodustat",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. \u00a0A) Daprodustat</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Daprodustat is a novel oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) used to treat anemia in CKD patients. It offers an alternative to injectable erythropoiesis-stimulating agents by promoting endogenous erythropoietin production through the HIF pathway.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bff191b8",
      "audio": ""
    },
    {
      "text": "All of the following are HMG-CoA reductase inhibitors except:",
      "options": [
        {
          "label": "A",
          "text": "Simvastatin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Atorvastatin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cilastatin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lovastatin",
          "correct": false
        }
      ],
      "correct_answer": "C. Cilastatin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Cilastatin</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cilastatin is not a statin and has no role in cholesterol metabolism, while Simvastatin , Atorvastatin , and Lovastatin are HMG-CoA reductase inhibitors used in the treatment of hyperlipidemia.</li><li>\u27a4 Cilastatin</li><li>\u27a4 Simvastatin</li><li>\u27a4 Atorvastatin</li><li>\u27a4 Lovastatin</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7a928e16",
      "audio": ""
    },
    {
      "text": "Which of the following regarding Angiotensin II Receptor Blockers (ARBs) is not correctly matched?",
      "options": [
        {
          "label": "A",
          "text": "Losartan: Thromboxane A2 receptor antagonist",
          "correct": false
        },
        {
          "label": "B",
          "text": "Telmisartan: Can reverse insulin resistance",
          "correct": false
        },
        {
          "label": "C",
          "text": "Olmesartan: Causes hypokalaemia in patients with CKD",
          "correct": true
        },
        {
          "label": "D",
          "text": "Valsartan: Given in combination with sacubitril as ARNI",
          "correct": false
        }
      ],
      "correct_answer": "C. Olmesartan: Causes hypokalaemia in patients with CKD",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Olmesartan: Causes hypokalaemia in patients with CKD.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Understand that ARBs generally cause hyperkalemia in patients with chronic kidney disease due to aldosterone inhibition, and Olmesartan is no exception. This contrasts with the false statement regarding hypokalemia . Additionally, recognize the unique benefits of Telmisartan in insulin resistance and Valsartan in combination therapy with sacubitril.</li><li>\u27a4 hyperkalemia</li><li>\u27a4 Olmesartan</li><li>\u27a4 hypokalemia</li><li>\u27a4 Telmisartan</li><li>\u27a4 Valsartan</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "501968ba",
      "audio": ""
    },
    {
      "text": "Some gram-negative bacteria produce an enzyme that blocks the action of beta lactam antibiotics in periplasmic space. Which arrow in the structural diagram of Penicillin G denotes the site of action of this enzyme?",
      "options": [
        {
          "label": "A",
          "text": "A",
          "correct": true
        },
        {
          "label": "B",
          "text": "B",
          "correct": false
        },
        {
          "label": "C",
          "text": "C",
          "correct": false
        },
        {
          "label": "D",
          "text": "D",
          "correct": false
        }
      ],
      "correct_answer": "A. A",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-171731.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) A</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "18526aa2",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT an NMDA receptor antagonist?",
      "options": [
        {
          "label": "A",
          "text": "Ketamine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Memantine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Amantadine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Flumazenil",
          "correct": true
        }
      ],
      "correct_answer": "D. Flumazenil",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Flumazenil</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Recognize that Ketamine , Memantine , and Amantadine are NMDA receptor antagonists . However, Flumazenil is a GABA-A receptor antagonist , and it does not interact with NMDA receptors.</li><li>\u27a4 Ketamine</li><li>\u27a4 Memantine</li><li>\u27a4 Amantadine</li><li>\u27a4 NMDA receptor antagonists</li><li>\u27a4 Flumazenil</li><li>\u27a4 GABA-A receptor antagonist</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9fc1140d",
      "audio": ""
    },
    {
      "text": "All adverse effects of theophylline are mediated by adenosine A1 receptor antagonism except:",
      "options": [
        {
          "label": "A",
          "text": "Cardiac arrhythmias",
          "correct": false
        },
        {
          "label": "B",
          "text": "Diuresis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Seizures",
          "correct": false
        },
        {
          "label": "D",
          "text": "GI discomfort",
          "correct": true
        }
      ],
      "correct_answer": "D. GI discomfort",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) GI discomfort</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Most of the adverse effects of theophylline , including cardiac arrhythmias , diuresis , and seizures , are mediated by its antagonism of adenosine A1 receptors . However, GI discomfort is not related to adenosine receptor antagonism but is due to direct effects on gastric secretion and mucosal irritation.</li><li>\u27a4 theophylline</li><li>\u27a4 cardiac arrhythmias</li><li>\u27a4 diuresis</li><li>\u27a4 seizures</li><li>\u27a4 adenosine A1 receptors</li><li>\u27a4 GI discomfort</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b80411f2",
      "audio": ""
    },
    {
      "text": "A 30-year-old male presented to emergency with head trauma due to road traffic accident. In hospital, the patient developed seizures. Emergency CT scan revealed widespread cerebral edema. Which of the following is diuretic of choice for cerebral edema in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Mannitol",
          "correct": true
        },
        {
          "label": "B",
          "text": "Spironolactone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Furosemide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hydrochlorothiazide",
          "correct": false
        }
      ],
      "correct_answer": "A. Mannitol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Mannitol</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "14df75f8",
      "audio": ""
    },
    {
      "text": "A 55-year-old female presented to oncologist with breast lump. On examination and investigations, breast cancer was diagnosed. Echocardiography of the patient shows ejection fraction of 25%. Which of the following drug will you avoid in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Daunorubicin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Irinotecan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cyclophosphamide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Methotrexate",
          "correct": false
        }
      ],
      "correct_answer": "A. Daunorubicin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Daunorubicin</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b82286bc",
      "audio": ""
    },
    {
      "text": "Adverse effect of orlistat is?",
      "options": [
        {
          "label": "A",
          "text": "Suicidal tendency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Steatorrhea",
          "correct": true
        },
        {
          "label": "C",
          "text": "Weight gain",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hyperglycemia",
          "correct": false
        }
      ],
      "correct_answer": "B. Steatorrhea",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Steatorrhea</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Orlistat is a useful medication for those looking to lose weight, especially in cases where diet and exercise alone have not been sufficient. Patients prescribed Orlistat should be counseled about the possibility of experiencing gastrointestinal side effects such as steatorrhea and advised on dietary adjustments to manage or minimize such effects, emphasizing a reduced fat intake.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "31aaa979",
      "audio": ""
    },
    {
      "text": "Which of the following drugs does not reduce mortality in patients with chronic heart failure?",
      "options": [
        {
          "label": "A",
          "text": "Valsartan plus Sacubitril",
          "correct": false
        },
        {
          "label": "B",
          "text": "Metoprolol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Telmisartan",
          "correct": false
        },
        {
          "label": "D",
          "text": "Furosemide",
          "correct": true
        }
      ],
      "correct_answer": "D. Furosemide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Furosemide</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ce521976",
      "audio": ""
    },
    {
      "text": "Which of the following adverse effects is least likely with the use of risperidone?",
      "options": [
        {
          "label": "A",
          "text": "Obesity",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hyperprolactinemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vomiting",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tardive dyskinesia",
          "correct": false
        }
      ],
      "correct_answer": "C. Vomiting",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Vomiting</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Risperidone , an atypical antipsychotic, is associated with side effects such as obesity , hyperprolactinemia , and, less frequently, tardive dyskinesia . However, due to its antiemetic properties , it is least likely to cause vomiting.</li><li>\u27a4 Risperidone</li><li>\u27a4 obesity</li><li>\u27a4 hyperprolactinemia</li><li>\u27a4 tardive dyskinesia</li><li>\u27a4 antiemetic properties</li><li>\u27a4 least likely</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5b6e357a",
      "audio": ""
    }
  ]
}